Cm Management, LLC Immuno Gen, Inc. Transaction History

Cm Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$4.48 - $6.47 $112,000 - $161,750	25,000 Added 5.26%	500,000 $2.39 Million
Q2 2022 Aug 08, 2022	BUY	$3.15 - $5.76 $78,750 - $144,000	25,000 Added 5.56%	475,000 $2.14 Million
Q1 2022 May 09, 2022	BUY	$4.26 - $7.48 $319,500 - $561,000	75,000 Added 20.0%	450,000 $2.14 Million
Q4 2020 Feb 04, 2021	BUY	$3.7 - $7.66 $1.39 Million - $2.87 Million	375,000 New	375,000 $2.42 Million

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Cm Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cm Management, LLC with notifications on news.